{"product_id":"balloon-pulmonary-angioplasty-in-patients-with-cteph-9783030959999","title":"Balloon pulmonary angioplasty in patients with CTEPH","description":"\u003cp\u003e\u003c\/p\u003e\u003cblockquote\u003eThe only curative treatment for CTEPH is surgical pulmonary endoarterectomy (PEA), but many patients may have high risk factors, peripheral diseases, or residual pulmonary hypertension. Balloon pulmonary angioplasty (BPA) is a recently developed alternative treatment that has proven efficacy and relative safety. This book offers a valuable reference guide for introducing or improving a BPA program, as well as for treating this complex patient population. \u003c\/blockquote\u003e\u003cp\u003e\u003cstrong\u003eFormat\u003c\/strong\u003e: Paperback \/ softback\u003cbr\u003e\u003cstrong\u003eLength\u003c\/strong\u003e: 130 pages\u003cbr\u003e\u003cstrong\u003ePublication date\u003c\/strong\u003e: 28 June 2023\u003cbr\u003e\u003cstrong\u003ePublisher\u003c\/strong\u003e: Springer Nature Switzerland AG\u003cbr\u003e\u003c\/p\u003e \u003cp\u003e\u003cbr\u003eThe only curative treatment currently available for chronic thromboembolic pulmonary hypertension (CTEPH) is surgical pulmonary endoarterectomy (PEA). However, several patients may have high risk factors for surgery, or a peripheral disease not amenable to surgical treatment; or else a residual pulmonary hypertension after PEA. Balloon pulmonary angioplasty (BPA) was recently developed to offer an alternative treatment for these patients. Extensive data has since confirmed the efficacy and relative safety of this procedure. However, there are several technical issues that have yet to be resolved. In addition, many cardiologists and pneumologists still know very little about the procedure itself and its potential. Exploring the clinical indications and technical aspects of BPA, this book offers a valuable reference guide for all those who would like to introduce or improve a BPA program, and for all those whose work involves treating this complex patient population.\u003cbr\u003e\u003cbr\u003e\u003c\/p\u003e\u003cp\u003eThe only curative treatment currently available for chronic thromboembolic pulmonary hypertension (CTEPH) is surgical pulmonary endoarterectomy (PEA). However, several patients may have high risk factors for surgery, or a peripheral disease not amenable to surgical treatment; or else a residual pulmonary hypertension after PEA.\u003c\/p\u003e\u003cp\u003eBalloon pulmonary angioplasty (BPA) was recently developed to offer an alternative treatment for these patients.\u003c\/p\u003e\u003cp\u003eExtensive data has since confirmed the efficacy and relative safety of this procedure.\u003c\/p\u003e\u003cp\u003eHowever, there are several technical issues that have yet to be resolved.\u003c\/p\u003e\u003cp\u003eIn addition, many cardiologists and pneumologists still know very little about the procedure itself and its potential.\u003c\/p\u003e\u003cp\u003eExploring the clinical indications and technical aspects of BPA, this book offers a valuable reference guide for all those who would like to introduce or improve a BPA program, and for all those whose work involves treating this complex patient population.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eWeight\u003c\/strong\u003e: 281g\u003cbr\u003e\u003cstrong\u003eDimension\u003c\/strong\u003e: 254 x 178 (mm)\u003cbr\u003e\u003cstrong\u003eISBN-13\u003c\/strong\u003e: 9783030959999\u003cbr\u003e \u003cstrong\u003eEdition number\u003c\/strong\u003e: 1st ed. 2022\u003c\/p\u003e","brand":"Shulph Ink","offers":[{"title":"Paperback \/ softback","offer_id":44346652262650,"sku":"9783030959999","price":62.46,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0522\/4297\/2845\/products\/1689346435742_book.jpg?v=1689353667","url":"https:\/\/shulphink.com\/products\/balloon-pulmonary-angioplasty-in-patients-with-cteph-9783030959999","provider":"Shulph Ink","version":"1.0","type":"link"}